Kelun-Biotech has become the second drugmaker to bring a TROP2-directed antibody-drug conjugate to regulatory approval, getting a green light in China for sacituzumab tirumotecan (sac-TMT). The ...

Banks have vastly evolved over the last 50 years but the underlying global financial system has remained largely the same; obscure and inefficient. The advent of regulated digital assets and ...

It's a good product with great design and can easly transfer from one place to another. No need to purchase stablizer with this.